1. Scrip

China Coronavirus Cases Up Sharply As Pharma Rushes To Aid

Kaletra Finding Off-Label Use

 
• By Brian Yang

AbbVie’s HIV therapy Kaletra is now being used by the Chinese government to treat coronavirus-infected patients after a respiratory expert endorsed its use, while other pharma companies from Bayer to Innovent are showering support as China battles its worst virus outbreak since the SARS epidemic 17 years ago.

STAFF WEARING MASKS CHECK PASSENGER TEMPERATURE AT BEIJING SUBWAY ON JAN, 28, 2020
STAFF SCREEN PASSENGERS AT A BEIJING SUBWAY STATION • Source: Scrip

US pharma major AbbVie Inc.'s HIV combination drug Kaletra(lopinavir and ritonavir), in combination with nebulized alpha-interferon, is being used by the Chinese government to treat patients with the new 2019-nCoV coronavirus.

The first boosted protease inhibitor, Kaletra is indicated in China as a second-line therapy for HIV patients and has been included in the National Anti-HIV

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from China

More from Focus On Asia